Utility of Exparel Based ESP Blocks in Elective Posterior Spine Fusion

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Spine FusionAnesthesia, Local
Interventions
DRUG

Liposomal bupivacaine

Patients will receive either liposomal bupivacaine as part of the ESPB .

DRUG

Bupivacaine

This is the control group comparator as this is standard of care at the investigator's institution.

All Listed Sponsors
lead

Hartford Hospital

OTHER